共 50 条
- [34] Neutrophil-to-lymphocyte ratio predicts the outcome of recurrent gastric cancer [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (03): : 5238 - 5242
- [35] The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma [J]. European Archives of Oto-Rhino-Laryngology, 2017, 274 : 535 - 542
- [37] High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2022, 42
- [39] Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer [J]. British Journal of Cancer, 2015, 113 : 150 - 158